Full Professor(heuristic)

Bladder and Urothelial Cancer Treatments · Surgery

h-index56
i10-index134
Publications524
Citations25,318

Grants

12 total · 8 active

NIH #5R01CA296335-02

The Role of EP300 Mutations in Bladder Cancer Pathogenesis and Drug Response

Active
Amount
$584K
Period
2025-01-01 → 2029-12-31
PIs
2
Est. capacity / PI
~3 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #1R01CA296335-01

The Role of EP300 Mutations in Bladder Cancer Pathogenesis and Drug Response

Active
Amount
$584K
Period
2025-01-01 → 2029-12-31
PIs
2
Est. capacity / PI
~3 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #3T32CA009207-47S1

Investigational Cancer Therapeutics Training Program (ICTTP)

Active
Amount
$6K
Period
1977-09-30 → 2029-08-31
PIs
3
Est. capacity / PI
~0 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.

All Grants

12 total · 8 active

NIH #5R01CA296335-02

The Role of EP300 Mutations in Bladder Cancer Pathogenesis and Drug Response

Active
Amount
$584K
Period
2025-01-01 → 2029-12-31
PIs
2
Est. capacity / PI
~3 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #1R01CA296335-01

The Role of EP300 Mutations in Bladder Cancer Pathogenesis and Drug Response

Active
Amount
$584K
Period
2025-01-01 → 2029-12-31
PIs
2
Est. capacity / PI
~3 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #3T32CA009207-47S1

Investigational Cancer Therapeutics Training Program (ICTTP)

Active
Amount
$6K
Period
1977-09-30 → 2029-08-31
PIs
3
Est. capacity / PI
~0 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #5T32CA009207-47

Investigational Cancer Therapeutics Training Program (ICTTP)

Active
Amount
$60K
Period
1977-09-30 → 2029-08-31
PIs
3
Est. capacity / PI
~0 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #2T32CA009207-46

Investigational Cancer Therapeutics Training Program (ICTTP)

Active
Amount
$584K
Period
1977-09-30 → 2029-08-31
PIs
3
Est. capacity / PI
~0 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #5R01CA288692-03

HER2 PET imaging to assess HER2 heterogeneity and predict response to HER2-targeted ADC therapy in urothelial carcinoma

Active
Amount
$594K
Period
2024-04-01 → 2029-03-31
PIs
3
Est. capacity / PI
~1 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #5R01CA288692-02

HER2 PET imaging to assess HER2 heterogeneity and predict response to HER2-targeted ADC therapy in urothelial carcinoma

Active
Amount
$557K
Period
2024-04-01 → 2029-03-31
PIs
3
Est. capacity / PI
~1 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #1R01CA288692-01

HER2 PET imaging to assess HER2 heterogeneity and predict response to HER2-targeted ADC therapy in urothelial carcinoma

Active
Amount
$557K
Period
2024-04-01 → 2029-03-31
PIs
3
Est. capacity / PI
~1 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #5R21CA267518-02

Combining BET protein inhibitors with radiation in HPV oropharyngeal cancer

Amount
$167K
Period
2022-12-08 → 2025-11-30
PIs
1
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF WISCONSIN-MADISON

NIH #1R21CA267518-01A1

Combining BET protein inhibitors with radiation in HPV oropharyngeal cancer

Amount
$212K
Period
2022-12-08 → 2024-11-30
PIs
1
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF WISCONSIN-MADISON

NIH #5T32CA009207-45

Investigational Cancer Therapeutics Training Program

Amount
$759K
Period
1977-09-30 → 2024-08-31
PIs
3
Est. capacity / PI
~0 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #5T32CA009207-44

Investigational Cancer Therapeutics Training Program

Amount
$576K
Period
1977-09-30 → 2024-08-31
PIs
3
Est. capacity / PI
~0 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

Potential Collaborators

Recent Publications

Last 2 years · showing 20 of 78
Open author page on OpenAlex →